IBDEI23H ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,35530,2)
 ;;=^5007178
 ;;^UTILITY(U,$J,358.3,35531,0)
 ;;=I21.4^^134^1722^57
 ;;^UTILITY(U,$J,358.3,35531,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35531,1,3,0)
 ;;=3^NSTEMI Myocardial Infarction
 ;;^UTILITY(U,$J,358.3,35531,1,4,0)
 ;;=4^I21.4
 ;;^UTILITY(U,$J,358.3,35531,2)
 ;;=^5007088
 ;;^UTILITY(U,$J,358.3,35532,0)
 ;;=I42.8^^134^1722^46
 ;;^UTILITY(U,$J,358.3,35532,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35532,1,3,0)
 ;;=3^Cardiomypathies NEC
 ;;^UTILITY(U,$J,358.3,35532,1,4,0)
 ;;=4^I42.8
 ;;^UTILITY(U,$J,358.3,35532,2)
 ;;=^5007199
 ;;^UTILITY(U,$J,358.3,35533,0)
 ;;=I20.8^^134^1722^7
 ;;^UTILITY(U,$J,358.3,35533,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35533,1,3,0)
 ;;=3^Angina Pectoris NEC
 ;;^UTILITY(U,$J,358.3,35533,1,4,0)
 ;;=4^I20.8
 ;;^UTILITY(U,$J,358.3,35533,2)
 ;;=^5007078
 ;;^UTILITY(U,$J,358.3,35534,0)
 ;;=I42.2^^134^1722^56
 ;;^UTILITY(U,$J,358.3,35534,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35534,1,3,0)
 ;;=3^Hypertrophic Cardiomyopathy NEC
 ;;^UTILITY(U,$J,358.3,35534,1,4,0)
 ;;=4^I42.2
 ;;^UTILITY(U,$J,358.3,35534,2)
 ;;=^340521
 ;;^UTILITY(U,$J,358.3,35535,0)
 ;;=I35.8^^134^1722^59
 ;;^UTILITY(U,$J,358.3,35535,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35535,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorders NEC
 ;;^UTILITY(U,$J,358.3,35535,1,4,0)
 ;;=4^I35.8
 ;;^UTILITY(U,$J,358.3,35535,2)
 ;;=^5007177
 ;;^UTILITY(U,$J,358.3,35536,0)
 ;;=I42.5^^134^1722^65
 ;;^UTILITY(U,$J,358.3,35536,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35536,1,3,0)
 ;;=3^Restrictive Cardiomyopathy NEC
 ;;^UTILITY(U,$J,358.3,35536,1,4,0)
 ;;=4^I42.5
 ;;^UTILITY(U,$J,358.3,35536,2)
 ;;=^5007196
 ;;^UTILITY(U,$J,358.3,35537,0)
 ;;=I05.8^^134^1722^69
 ;;^UTILITY(U,$J,358.3,35537,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35537,1,3,0)
 ;;=3^Rheumatic Mitral Valve Diseases NEC
 ;;^UTILITY(U,$J,358.3,35537,1,4,0)
 ;;=4^I05.8
 ;;^UTILITY(U,$J,358.3,35537,2)
 ;;=^5007043
 ;;^UTILITY(U,$J,358.3,35538,0)
 ;;=I08.8^^134^1722^70
 ;;^UTILITY(U,$J,358.3,35538,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35538,1,3,0)
 ;;=3^Rheumatic Multiple Valve Diseases NEC
 ;;^UTILITY(U,$J,358.3,35538,1,4,0)
 ;;=4^I08.8
 ;;^UTILITY(U,$J,358.3,35538,2)
 ;;=^5007056
 ;;^UTILITY(U,$J,358.3,35539,0)
 ;;=I47.9^^134^1722^63
 ;;^UTILITY(U,$J,358.3,35539,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35539,1,3,0)
 ;;=3^Paroxysmal Tachycardia,Unspec
 ;;^UTILITY(U,$J,358.3,35539,1,4,0)
 ;;=4^I47.9
 ;;^UTILITY(U,$J,358.3,35539,2)
 ;;=^5007224
 ;;^UTILITY(U,$J,358.3,35540,0)
 ;;=I05.1^^134^1722^66
 ;;^UTILITY(U,$J,358.3,35540,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35540,1,3,0)
 ;;=3^Rheumatic Mitral Insufficiency
 ;;^UTILITY(U,$J,358.3,35540,1,4,0)
 ;;=4^I05.1
 ;;^UTILITY(U,$J,358.3,35540,2)
 ;;=^269568
 ;;^UTILITY(U,$J,358.3,35541,0)
 ;;=I05.0^^134^1722^67
 ;;^UTILITY(U,$J,358.3,35541,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35541,1,3,0)
 ;;=3^Rheumatic Mitral Stenosis
 ;;^UTILITY(U,$J,358.3,35541,1,4,0)
 ;;=4^I05.0
 ;;^UTILITY(U,$J,358.3,35541,2)
 ;;=^5007041
 ;;^UTILITY(U,$J,358.3,35542,0)
 ;;=I05.9^^134^1722^68
 ;;^UTILITY(U,$J,358.3,35542,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35542,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,35542,1,4,0)
 ;;=4^I05.9
 ;;^UTILITY(U,$J,358.3,35542,2)
 ;;=^5007044
 ;;^UTILITY(U,$J,358.3,35543,0)
 ;;=I21.3^^134^1722^71
 ;;^UTILITY(U,$J,358.3,35543,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,35543,1,3,0)
 ;;=3^STEMI Myocardial Infarction,Unspec Site
 ;;^UTILITY(U,$J,358.3,35543,1,4,0)
 ;;=4^I21.3
 ;;^UTILITY(U,$J,358.3,35543,2)
 ;;=^5007087
